MaxCyte Inc MXCT:NASDAQ

Last Price$5.25NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/28/22

Today's Change+0.30(6.06%)
Bid (Size)$4.56 (1)
Ask (Size)$5.65 (1)
Day Low / High$4.80 - 5.34
Volume272.00
 

View Biotechnology IndustryPeer Comparison as of 06/28/2022

 

MaxCyte Inc ( NASDAQ )

Price: $5.25
Change: +0.30 (6.06%)
Volume: 272.00
4:00PM ET 6/28/2022
 
 

Rapt Therapeutics Inc ( NASDAQ )

Price: $18.02
Change: -0.80 (4.25%)
Volume: 157.3 K
4:00PM ET 6/28/2022
 
 

Stoke Therapeutics Inc ( NASDAQ )

Price: $12.96
Change: -0.47 (3.50%)
Volume: 177.2 K
4:00PM ET 6/28/2022
 
 

Altimmune Inc ( NASDAQ )

Price: $11.64
Change: -0.11 (0.94%)
Volume: 107.00
4:00PM ET 6/28/2022
 
 

Kezar Life Sciences Inc ( NASDAQ )

Price: $8.29
Change: +2.51 (43.43%)
Volume: 16.2 K
4:00PM ET 6/28/2022
 

Read more news Recent News

--Stifel Nicolaus Adjusts Price Target for MaxCyte tp $16 From $18, Maintains Buy Rating
1:54PM ET 5/10/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (MXCT) MAXCYTE Reports Q1 Revenue $11.6M, vs. Street Est of $8.5M
4:41PM ET 5/09/2022 MT Newswires

...

MaxCyte Says CFO Murphy Leaving Company; Preliminary Q1 Revenue Ahead of Estimates
4:28PM ET 4/12/2022 MT Newswires

MaxCyte (MXCT) said Tuesday it has named its chief accounting officer Ron Holtz as its interim CFO, succeeding Amanda Murphy who has resigned from her...

MaxCyte Q4 Loss Widens as Revenue Rises
4:31PM ET 3/22/2022 MT Newswires

MaxCyte (MXCT) on Tuesday reported a Q4 net loss of $0.05 per share, compared with a loss of $0.03 per share a year earlier. Analysts polled by Capital IQ...

View all Commentary and Analysis

Tracking Ron Baron's BAMCO Portfolio - Q1 2022 Update
11:04PM ET 6/23/2022 Seeking Alpha

MaxCyte (MXCT) Investor Presentation - Slideshow
11:35AM ET 5/10/2022 Seeking Alpha

MaxCyte, Inc. (MXCT) CEO Doug Doerfler on Q1 2022 Results - Earnings Call Transcript
9:18PM ET 5/09/2022 Seeking Alpha

Tracking Ron Baron's BAMCO Portfolio - Q4 2021 Update
11:37PM ET 3/27/2022 Seeking Alpha

Company Profile

Business Description
Number of EmployeesN/A
Recent SEC Filing05/26/2022DEF 14A

Company Highlights

Price Open$4.95
Previous Close$5.25
52 Week Range$3.36 - 17.44
Market Capitalization$533.1 M
Shares Outstanding101.5 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement09/12/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.17
Beta vs. S&P 500N/A
RevenueN/A
Net Profit Margin-41.15%
Return on Equity-7.39%

Analyst Ratings as of 11/11/2021

Buy
7
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset